Results 61 to 70 of about 651 (115)

Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: clinical, biochemical and molecular characteristics and long-term outcomes

open access: yesAnales de Pediatría (English Edition)
Introduction: 11β-hydroxylase (11β-OH) deficiency is the second most frequent cause of classic congenital adrenal hyperplasia (CAH) (5%–8% of cases). Clinically, it is characterized by virilization and arterial hypertension.
Elida Mercado Santis   +6 more
doaj   +1 more source

Bringing the Pediatric Endocrine Spanish Speaking Community Together: First Virtual Pediatric Endocrine Meeting in Low- and Middle-Income Countries in Central and South America. [PDF]

open access: yesInteract J Med Res, 2023
Bogarin R   +9 more
europepmc   +1 more source

Do GnRH Agonists Really Increase Body Weight Gain? Evaluation of a Multicentric Portuguese Cohort of Patients With Central Precocious Puberty. [PDF]

open access: yesFront Pediatr, 2022
Leite AL   +8 more
europepmc   +1 more source

Correction: Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study. [PDF]

open access: yesJMIR Pediatr Parent
Jiménez-Díaz A   +10 more
europepmc   +1 more source

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023. [PDF]

open access: yesEndocr Connect
Roxas A   +70 more
europepmc   +1 more source

Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study. [PDF]

open access: yesActa Biomed, 2022
Giugno A   +8 more
europepmc   +1 more source

Peripheral precocious puberty in girls with McCune-Albright syndrome: a case series. [PDF]

open access: yesArch Endocrinol Metab
Faria AG   +17 more
europepmc   +1 more source

Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. [PDF]

open access: yesJ Clin Med, 2023
Carcavilla A   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy